Cliff Asness’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $225M | Buy |
2,582,561
+2,176,356
| +536% | +$131M | 0.08% | 350 |
|
|
2026
Q1 | $15.9M | Sell |
406,205
-481,656
| -54% | -$18M | 0.01% | 1121 |
|
|
2025
Q4 | $30.9M | Sell |
887,861
-619,348
| -41% | -$48.6M | 0.02% | 808 |
|
|
2025
Q3 | $125M | Buy |
1,507,209
+1,274,215
| +547% | +$92.2M | 0.08% | 353 |
|
|
2025
Q2 | $17.1M | Sell |
232,994
-20,036
| -8% | -$1.45M | 0.01% | 830 |
|
|
2025
Q1 | $28.9M | Sell |
253,030
-23,561
| -9% | -$1.43M | 0.03% | 604 |
|
|
2024
Q4 | $13.9M | Sell |
276,591
-39,364
| -12% | -$2.06M | 0.02% | 739 |
|
|
2024
Q3 | $14.6M | Buy |
315,955
+76,900
| +32% | +$2.73M | 0.02% | 708 |
|
|
2024
Q2 | $7.77M | Sell |
239,055
-19,353
| -7% | -$530K | 0.01% | 839 |
|
|
2024
Q1 | $6.51M | Buy |
258,408
+166,975
| +183% | +$3.94M | 0.01% | 871 |
|
|
2023
Q4 | $2.97M | Buy |
91,433
+11,488
| +14% | +$315K | 0.01% | 1172 |
|
|
2023
Q3 | $2.18M | Buy |
79,945
+416
| +0.5% | +$12K | ﹤0.01% | 1286 |
|
|
2023
Q2 | $1.77M | Sell |
79,529
-4,745
| -6% | -$109K | ﹤0.01% | 1311 |
|
|
2023
Q1 | $1.83M | Buy |
84,274
+13,487
| +19% | +$296K | ﹤0.01% | 1294 |
|
|
2022
Q4 | $1.44M | Sell |
70,787
-2,172
| -3% | -$54.4K | ﹤0.01% | 1406 |
|
|
2022
Q3 | $1.87M | Sell |
72,959
-18,213
| -20% | -$487K | ﹤0.01% | 1234 |
|
|
2022
Q2 | $2.17M | Buy |
91,172
+7,788
| +9% | +$170K | ﹤0.01% | 1066 |
|
|
2022
Q1 | $1.88M | Buy |
83,384
+8,266
| +11% | +$176K | ﹤0.01% | 1217 |
|
|
2021
Q4 | $1.49M | Sell |
75,118
-19,005
| -20% | -$386K | ﹤0.01% | 1352 |
|
|
2021
Q3 | $1.85M | Sell |
94,123
-2,875
| -3% | -$60.2K | ﹤0.01% | 1192 |
|
|
2021
Q2 | $2.13M | Sell |
96,998
-6,120
| -6% | -$136K | ﹤0.01% | 1187 |
|
|
2021
Q1 | $2.45M | Sell |
103,118
-41,543
| -29% | -$1.11M | ﹤0.01% | 1112 |
|
|
2020
Q4 | $3.78M | Sell |
144,661
-123,166
| -46% | -$2.59M | 0.01% | 875 |
|
|
2020
Q3 | $4.66M | Sell |
267,827
-52,435
| -16% | -$836K | 0.01% | 794 |
|
|
2020
Q2 | $5.39M | Buy |
320,262
+17,628
| +6% | +$248K | 0.01% | 764 |
|
|
2020
Q1 | $3.6M | Buy |
302,634
+178,597
| +144% | +$2.21M | 0.01% | 886 |
|
|
2019
Q4 | $1.5M | Sell |
124,037
-77,681
| -39% | -$1.08M | ﹤0.01% | 1381 |
|
|
2019
Q3 | $2.85M | Buy |
201,718
+656
| +0.3% | +$8.06K | ﹤0.01% | 1159 |
|
|
2019
Q2 | $2.24M | Buy |
201,062
+46,874
| +30% | +$522K | ﹤0.01% | 1226 |
|
|
2019
Q1 | $1.81M | Buy |
154,188
+31,538
| +26% | +$392K | ﹤0.01% | 1352 |
|
|
2018
Q4 | $1.64M | Sell |
122,650
-115,960
| -49% | -$1.53M | ﹤0.01% | 1321 |
|
|
2018
Q3 | $3.35M | Sell |
238,610
-121,115
| -34% | -$1.69M | ﹤0.01% | 1171 |
|
|
2018
Q2 | $5.66M | Buy |
359,725
+11,977
| +3% | +$208K | 0.01% | 972 |
|
|
2018
Q1 | $5.72M | Sell |
347,748
-363,267
| -51% | -$6.73M | 0.01% | 949 |
|
|
2017
Q4 | $12.8M | Sell |
711,015
-223,369
| -24% | -$4.05M | 0.01% | 706 |
|
|
2017
Q3 | $18M | Buy |
934,384
+284,811
| +44% | +$4.25M | 0.02% | 616 |
|
|
2017
Q2 | $7.67M | Buy |
649,573
+289,958
| +81% | +$3.15M | 0.01% | 877 |
|
|
2017
Q1 | $3.94M | Buy |
359,615
+217,323
| +153% | +$1.91M | 0.01% | 1115 |
|
|
2016
Q4 | $1.03M | Buy |
142,292
+22,313
| +19% | +$175K | ﹤0.01% | 1681 |
|
|
2016
Q3 | $780K | Buy |
119,979
+23,175
| +24% | +$135K | ﹤0.01% | 1803 |
|
|
2016
Q2 | $529K | Sell |
96,804
-103,929
| -52% | -$541K | ﹤0.01% | 1857 |
|
|
2016
Q1 | $939K | Sell |
200,733
-90,049
| -31% | -$351K | ﹤0.01% | 1602 |
|
|
2015
Q4 | $1.45M | Buy |
290,782
+124,840
| +75% | +$563K | ﹤0.01% | 1411 |
|
|
2015
Q3 | $624K | Buy |
165,942
+110,461
| +199% | +$561K | ﹤0.01% | 1642 |
|
|
2015
Q2 | $333K | Buy |
55,481
+13,281
| +31% | +$81.4K | ﹤0.01% | 1937 |
|
|
2015
Q1 | $236K | Sell |
42,200
-20,200
| -32% | -$73.1K | ﹤0.01% | 1961 |
|
|
2014
Q4 | $187K | Sell |
62,400
-22,800
| -27% | -$69.5K | ﹤0.01% | 2379 |
|
|
2014
Q3 | $228K | Hold |
85,200
| – | – | ﹤0.01% | 2295 |
|
|
2014
Q2 | $239K | Buy |
85,200
+26,300
| +45% | +$77.6K | ﹤0.01% | 2304 |
|
|
2014
Q1 | $257K | Buy |
+58,900
| New | +$206K | ﹤0.01% | 2331 |
|
Other funds holding CORT
ISL
PA
Cliff Asness's CORT Position: Q2 2026 in Review
Cliff Asness increased its Corcept Therapeutics (CORT) stake by 536% in Q2 2026, buying an estimated $131M and bringing the position to 2,582,561 shares worth $225M. The position accounts for 0.08% of the portfolio, ranked #350.
Cliff Asness first reported a position in CORT in Q1 2014 and has held it in 50 quarters since. 420 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Cliff Asness held 2,582,561 shares of Corcept Therapeutics worth $225M as of Q2 2026.
- Cliff Asness bought 2,176,356 Corcept Therapeutics shares in Q2 2026, an estimated $131M.
- Corcept Therapeutics made up 0.08% of Cliff Asness's portfolio in Q2 2026, its #350 holding.
- Cliff Asness first reported a position in Corcept Therapeutics in Q1 2014 and has held it in 50 quarters since.
- 420 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.